Rheumatoid arthritis (RA)
Renuka Nayak, MD, PhD
University of California, San Francisco (UCSF)
San Francisco, CA, United States
Disclosure(s): No financial relationships to disclose
Vivian Bykerk, MD, FRCPC
Hospital for Special Surgery
New York, NY, United States
Disclosure(s): Amgen: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Crossbridge: Advisor or Review Panel Member (Terminated, December 1, 2021); Genzyme: Advisor or Review Panel Member (Terminated); Gilead: Consultant (Terminated, February 28, 2020); Janssen: Advisor or Review Panel Member (Terminated, December 1, 2021); Pfizer: Advisor or Review Panel Member (Terminated, December 1, 2021), Grant/Research Support (Terminated, December 1, 2021); Regeneron: Advisor or Review Panel Member (Terminated, December 1, 2019); Sanofi: Advisor or Review Panel Member (Ongoing); UCB: Consultant (Terminated, December 1, 2018)
Oral abstract session.
Presenting Author: Juergen Rech, MD – University Clinic Erlangen
Presenting Author: Espen Riskedal, MSc – Age Labs AS, Oslo, Norway
Presenting Author: Orit Schieir, PhD – McGill University
Presenting Author: Timothy Wilson, MD – Thomas Jefferson University
Presenting Author: Clément Triaille, n/a – Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain
Presenting Author: Duncan Porter, MD – Gartnavel General Hospital